威高骨科收盘上涨2.26%，滚动市盈率48.84倍，总市值117.52亿元

Core Viewpoint - Weigao Orthopedics has seen a recent stock price increase, with a closing price of 29.38 yuan, marking a 2.26% rise, while its rolling PE ratio has reached a new low of 48.84 times over the past 78 days, with a total market capitalization of 11.752 billion yuan [1]. Company Overview - Weigao Orthopedics specializes in a wide range of orthopedic products, including spinal, trauma, joint, sports medicine, bone repair materials, tissue repair, and orthopedic surgical instruments, making it one of the most comprehensive and leading domestic orthopedic enterprises [1]. - The company holds a total of 371 patents, including 86 invention patents and 266 utility model patents [1]. Financial Performance - In the first quarter of 2025, Weigao Orthopedics reported an operating income of 290 million yuan, a year-on-year decrease of 16.59%, while net profit reached 51.79 million yuan, reflecting a year-on-year increase of 48.37%, with a gross profit margin of 63.68% [1]. Shareholder Information - As of March 31, 2025, Weigao Orthopedics had 8,904 shareholders, a decrease of 302 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1]. Industry Comparison - The average PE ratio for the medical device industry is 55.28 times, with a median of 38.06 times, positioning Weigao Orthopedics at 85th place within the industry [1][2].